Natus Medical to Hold 2020 Fourth Quarter Financial Results Conference Call on February 25th
Natus Medical (NASDAQ: NTUS) will announce its 2020 fourth-quarter financial results on February 25, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Natus Medical (NASDAQ: NTUS) will announce its 2020 fourth-quarter financial results on February 25, 2021, after market close. The management will host a conference call at 1:30 p.m. PT to discuss the results and address investor questions. Interested individuals can participate by calling 1-844-634-1441 (domestic) or 1-508-637-5658 (international). A telephone replay will be available for 48 hours post-call. The call will also be streamed online.
Natus specializes in medical device solutions for central nervous and sensory system disorders.
Details
News Market Reaction – NTUS
The recorded move for NTUS in the trading session of this news was +3.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 fourth quarter financial results after the close of the market on Thursday, February 25th. Natus management will host a conference call the same day beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 8646785. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 8646785.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.